Back to funds

Elmind Capital, LP

Updated 6 days ago

Managed by Elmind Capital, Lp • Latest filing Q3 2026

Portfolio value
$403.8M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$338.9M
Q1 2026$352.2M
Q2 2026$398M
Q3 2026$403.8M

Top holdings

30 positions as of Q3 2026

View filing
C

CELLDEX THERAPEUTICS INC NEW

Value
$36M
Shares
1.11M
% Port
8.91%
L

LEGEND BIOTECH CORP

Value
$31.2M
Shares
1.57M
% Port
7.73%
S

SYNDAX PHARMACEUTICALS INC

Value
$30.2M
Shares
1.60M
% Port
7.47%
C

COGENT BIOSCIENCES INC

Value
$27.8M
Shares
866.7K
% Port
6.87%
R

RELAY THERAPEUTICS INC

Value
$26.4M
Shares
1.47M
% Port
6.55%
A

AMYLYX PHARMACEUTICALS INC

Value
$26M
Shares
894.8K
% Port
6.45%
V

VIRIDIAN THERAPEUTICS INC

Value
$25.2M
Shares
1.22M
% Port
6.25%
P

VAXCYTE INC

Value
$21.2M
Shares
372.3K
% Port
5.25%
U

UROGEN PHARMA LTD

Value
$20M
Shares
491.1K
% Port
4.94%
T

TRAVERE THERAPEUTICS INC

Value
$19M
Shares
322.6K
% Port
4.70%
C

CULLINAN THERAPEUTICS INC

Value
$14.8M
Shares
962.8K
% Port
3.66%
P

PHARVARIS N V

Value
$14.5M
Shares
455.8K
% Port
3.58%
V

VERA THERAPEUTICS INC

Value
$14.1M
Shares
436.5K
% Port
3.49%
C

CYTOMX THERAPEUTICS INC.

Value
$12.4M
Shares
4.55M
% Port
3.06%
B

BEAM THERAPEUTICS INC

Value
$11.6M
Shares
476.3K
% Port
2.88%
N

NURIX THERAPEUTICS INC

Value
$10.9M
Shares
460.0K
% Port
2.70%
S

SUMMIT THERAPEUTICS INC

Value
$8.4M
Shares
493.8K
% Port
2.07%
U

UNITED THERAPEUTICS CORP DEL

Value
$8.1M
Shares
15.0K
% Port
2.01%
I

IMMUNOCORE HLDGS PLC

Value
$7.8M
Shares
256.1K
% Port
1.92%
K

KRYSTAL BIOTECH INC

Value
$7.3M
Shares
22.0K
% Port
1.81%

Explore